BRKRHIGH SIGNALFINANCIAL10-K

Bruker experienced a dramatic decline in operating performance with operating income falling substantially while the company strengthened its balance sheet through improved cash positioning and debt reduction.

The severe contraction in operating income signals potential fundamental challenges in the business, whether from market headwinds, operational inefficiencies, or strategic investments that have yet to generate returns. However, the simultaneous improvement in financial position through higher cash reserves and lower debt levels suggests management is taking prudent steps to preserve financial flexibility during this challenging period.

Comparing 2026-02-27 vs 2025-03-03View on EDGAR →
FINANCIAL ANALYSIS

Bruker's financial profile shows a stark divergence between operational performance and balance sheet health. While operating income declined substantially and operating cash flow dropped meaningfully, the company significantly bolstered its cash position to nearly $300M and reduced total debt by over 10%. The combination of weaker operational metrics with a stronger capital structure suggests either temporary headwinds or strategic investments that have compressed near-term profitability while management builds financial resilience.

FINANCIAL STATEMENT CHANGES
Operating Income
P&L
-73.1%
$253.1M$68.2M

Operating income deteriorated sharply — investigate whether driven by one-time charges or structural cost issues.

Cash & Equivalents
Balance Sheet
+62.9%
$183.4M$298.8M

Cash position surged 62.9% — strong cash generation or capital raise providing significant financial cushion.

Operating Cash Flow
Cash Flow
-46.6%
$251.3M$134.1M

Operating cash flow fell 46.6% — earnings quality concerns; investigate working capital changes and non-cash items.

Stockholders Equity
Balance Sheet
+37.9%
$1.8B$2.5B

Equity base grew 37.9% — retained earnings accumulation or equity issuance strengthening the balance sheet.

Capital Expenditure
Cash Flow
-21.2%
$115.3M$90.8M

Capex reduced 21.2% — investment cycle winding down or capital discipline; may improve near-term free cash flow.

Total Debt
Balance Sheet
-10.8%
$2.1B$1.9B

Debt reduced 10.8% — deleveraging strengthens balance sheet and reduces financial risk.

LANGUAGE CHANGES
NEW — 2026-02-27
PRIOR — 2025-03-03
ADDED
As of February 20, 2026, there were 152,219,250 of the registrant s common stock outstanding and 2,760,000 of the registrant s Series A mandatory convertible preferred stock outstanding.
Business Segments We have four reportable segments, Bruker Scientific Instruments ( BSI ) BioSpin, BSI CALID (Chemicals, Applied Markets, Life Science, In Vitro Diagnostics, Detection), BSI NANO, and Bruker Energy Supercon Technologies ( BEST ), which each comprise several divisions as disclosed below.
It offers comprehensive software solutions for workflow integration, automation, and artificial intelligence readiness, adhering to Findability, Accessibility, Interoperability, and Reusability ( FAIR ) data principles.
During 2025, we continued our focus on enhancing customer relationships and driving innovation with our key initiatives, which include expanding into high-potential markets, leveraging core strengths, and driving recurring revenue through aftermarket and connected services.
Furthermore, during 2025, we completed certain minority investments which align with the segment s goals of expanding its technological capabilities, entering new markets, and enhancing its product portfolio.
+7 more — sign up free →
REMOVED
Our principal executive offices are located at 40 Manning Road, Billerica, MA 01821, and our telephone number is (978) 663-3660.
Business Segments We have four reportable segments, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID (Chemicals, Applied Markets, Life Science, In Vitro Diagnostics, Detection), BSI NANO, and Bruker Energy Supercon Technologies (BEST).
Furthermore, BSI BioSpin s product enables the characterization of mixtures and also complex materials, rendering them high value-added tools for a variety of industrial applications.
It offers comprehensive software solutions for workflow integration, automation, and artificial intelligence readiness, adhering to Findability, Accessibility, Interoperability, and Reusability (FAIR) data principles.
Automation: Provides solutions for lab automation and digitalization in Research Development and Quality Control.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →